Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors

NCT07726446 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer (BTC)

Interventions

DRUG: PD-1 and chemotherapy
PROCEDURE: cryoablation

Sponsor

Tianjin Medical University Cancer Institute and Hospital